Pharmaceutical Firms Focus on Convenient Diabetes and Obesity Drugs
SEOUL, Aug. 14 (Korea Bizwire) — South Korean pharmaceutical companies, currently involved in developing drugs for diabetes and obesity, are emphasizing the improvement of usage convenience by extending drug efficacy durations and modifying formulations. Peptron Inc. is progressing toward transferring PT404, a sustained-release diabetes and obesity treatment formulation, to global pharmaceutical firms. Unlike existing treatments [...]